AKRO Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 112907 min ago

@ $22.13

Wydano: 14 vas. 2024 @ 21:43

Zwrot: -10.94%

Poprzedni sygnał: vas. 13 - 22:49

Poprzedni sygnał: Sprzedaż

Zwrot: 7.64 %

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 23:00):

Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health...

Stats
Dzisiejszy wolumen	427 727
Średni wolumen	1.41M
Kapitalizacja rynkowa	1.36B
EPS	$0 ( 2024-03-15 )
Następna data zysków	( $-0.860 ) 2024-05-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.82
ATR14	$0.0220 (0.11%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Young Jonathan	Sell	5 000	Common Stock
2024-04-29	Gangloff Scott A.	Buy	225 000	Stock Option (Right to Buy)
2024-04-29	Gangloff Scott A.	Buy	0
2024-04-01	Young Jonathan	Sell	4 600	Common Stock
2024-04-01	Young Jonathan	Sell	400	Common Stoek

INSIDER POWER
56.95
Last 99 transactions
Buy: 2 261 541 \| Sell: 619 470

Wolumen Korelacja

Długi: -0.20 (neutral)

Krótki: 0.25 (neutral)

Signal:(53.325) Neutral

Akero Therapeutics Inc Korelacja

10 Najbardziej pozytywne korelacje
AZYO	0.936
GNSS	0.933
VRAR	0.929
UBOH	0.929
NVCT	0.922
CULL	0.919
VERA	0.919
JRJC	0.918
EDSA	0.917
BRQS	0.91

10 Najbardziej negatywne korelacje
RXDX	-0.979
FLMN	-0.968
ZYNE	-0.962
RESN	-0.962
ZGNX	-0.959
CYT	-0.958
ADMS	-0.946
RETA	-0.946
ORTX	-0.938
XLRN	-0.931

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Akero Therapeutics Inc Korelacja - Waluta/Towar

0.17
( neutral )

-0.09
( neutral )

0.00
( neutral )

-0.38
( neutral )

-0.54
( weak negative )

Akero Therapeutics Inc Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-29 000.00 (0.00 %)
EPS:	$-2.89

FY	2023
Przychody:	$0
Zysk brutto:	$-29 000.00 (0.00 %)
EPS:	$-2.89

FY	2022
Przychody:	$0
Zysk brutto:	$-260 000 (0.00 %)
EPS:	$-2.79

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-2.89

Financial Reports:

No articles found.

Akero Therapeutics Inc

Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. It also conducts a Phase 2a clinical trial, the BALANCED study, to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.